FDA: Meeting of the FDA Drug Safety and Risk Management Advisory Committee: Dextromethorphan (FDA-2010-N-0001)

The Food Marketing Institute (FMI) appreciates the opportunity to provide comments to the Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee as it prepares to discuss the abuse potential of dextromethorphan as well as the public health benefits and risks of this ingredient as a cough suppressant.

Full Comments